Advertisement
Screener

PALISADE BIO, INC. (PALI) ROA

PALISADE BIO, INC. (PALI) ROA

  • 2026-06-30: ROA -25.09%.
  • 2026-03-31: ROA -18.12%.
  • 2025-12-31: ROA -12.49%.
  • 2025-09-30: ROA -160.99%.

Complete source-backed roa history.

Available history
2010-12-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-30-25.09%
2026-03-31-18.12%
2025-12-31-12.49%
2025-09-30-160.99%
2025-06-30-177.67%
2025-03-31-160.45%
2024-12-31-132.70%
2024-09-30-150.65%
2024-06-30-110.12%
2024-03-31-106.60%
2023-12-31-87.53%
2023-09-30-76.46%
2023-06-30-73.50%
2023-03-31-81.21%
2022-12-31-90.47%
2022-09-30-58.20%
2022-06-3033.45%
2022-03-31-320.85%
2021-12-31-212.72%
2021-09-30-196.22%
2021-06-30-280.04%
2021-03-31-134.25%
2020-12-31-341.90%
2020-09-30-53.50%
2020-06-30-46.99%
2020-03-31-67.09%
2019-12-31-126.85%
2019-09-30-74.18%
2019-06-30-190.29%
2019-03-31-108.99%
2018-12-31-64.09%
2018-09-30-102.58%
2018-06-30-67.40%
2018-03-31-88.71%
2017-12-31-112.83%
2017-09-30-109.62%
2017-06-30-172.09%
2017-03-31-117.66%
2016-12-31-93.23%
2016-09-30-241.92%
2016-06-30-156.91%
2016-03-31-220.19%
2015-12-31-139.83%
2015-09-30-102.37%
2015-06-30-77.58%
2015-03-31-70.66%
2014-12-31-75.82%
2014-09-30-69.38%
2014-06-30-69.45%
2014-03-31-61.69%
2013-12-31-102.15%
2013-09-30-100.41%
2013-06-30-109.68%
2013-03-31-73.06%
2012-12-31-115.67%
2012-09-30-88.62%
2012-06-30-267.79%
2012-03-31-173.37%
2011-12-31-306.36%
2011-09-30-215.68%
2011-06-30-180.85%

Annual ROA

DateROA
2025-12-31-12.49%
2024-12-31-132.70%
2023-12-31-87.53%
2022-12-31-90.47%
2021-12-31-212.72%
2020-12-31-341.90%
2019-12-31-126.85%
2018-12-31-64.09%
2017-12-31-112.83%
2016-12-31-93.23%
2015-12-31-139.83%
2014-12-31-75.82%
2013-12-31-102.15%
2012-12-31-115.67%
2011-12-31-306.36%
2010-12-31-173.61%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Lexeo Therapeutics, Inc. (LXEO)United States$0.278B-4.19
FATE THERAPEUTICS INC (FATE)United States$0.280B-2.51
Invivyd, Inc. (IVVD)United States$0.270B-2.42
Liminatus Pharma, Inc. (LIMN)United States$0.282B
SUTRO BIOPHARMA, INC. (STRO)United States$0.260B-3.05
Inhibikase Therapeutics, Inc. (IKT)United States$0.296B-4.44
X4 Pharmaceuticals, Inc (XFOR)United States$0.297B-4.99
SAB Biotherapeutics, Inc. (SABS)United States$0.306B-25.49
Century Therapeutics, Inc. (IPSC)United States$0.306B-4.02
Lineage Cell Therapeutics, Inc. (LCTX)United States$0.241B-10.35